sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia

Leukemia Research

Volumn 33, Issue 8, 2009, Pages 1062-1067

  Pehlivan, Melek ^a   Sercan, Zeynep ^a   Sercan, Hakki Ogun ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Chronic myeloid leukemia; Cytogenetics; Imatinib; Methylation; sFRP; Wnt signaling

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BETA CATENIN; CASPASE 3; DNA; IMATINIB; SECRETED FRIZZLED RELATED PROTEIN 1; WNT PROTEIN;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GENETICS; CANCER RESISTANCE; CELL STRAIN K 562; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DNA METHYLATION; DRUG POTENTIATION; EMBRYO; ENZYME ACTIVITY; EPIGENETICS; FEMALE; GENE SILENCING; GENETIC ASSOCIATION; GENETIC RESISTANCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROMOTER REGION; SCHOOL CHILD; UPREGULATION;

ADOLESCENT; ADULT; AGED; CHILD; DNA METHYLATION; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE SILENCING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHILADELPHIA CHROMOSOME; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 67349202157     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.11.013     Document Type: Article

References (31)

1. Logan C.Y., and Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20 (2004) 781-810
2. Widelitz R. Wnt signaling through canonical and non-canonical pathways: recent progress. Growth Factors 23 (2005) 111-116
3. Kawano Y., and Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116 (2003) 2627-2634
4. Prunier C., Hocevar B.A., and Howe P.H. Wnt signaling: physiology and pathology. Growth Factors 22 (2003) 141-150
5. van Es J.H., Barker N., and Clevers H. You Wnt some, you lose some: oncogenes in the Wnt signaling pathway. Curr Opin Genet Dev 13 (2003) 28-33
6. Jones S.E., and Jomary J. Secreted frizzled-related proteins: searching for relationships and patterns. Bioessays 24 (2002) 811-820
7. Polakis P. Wnt signaling and cancer. Genes Dev 14 (2000) 1837-1851
8. Khan N.I., and Bendall L.J. Role of WNT signaling in normal and malignant hematopoiesis. Histol Histopathol 21 (2006) 761-774
9. Staal F.J., and Clevers H.C. WNT signalling and haematopoiesis: a WNT-WNT situation. Nat Rev Immunol 5 (2005) 21-30
10. Reya T., Duncan A., Ailles L., Domen J., Scherer D.C., Willert K., et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423 (2003) 409-414
11. Rattis F.M., Voermans C., and Reya T. Wnt signaling in the stem cell niche. Curr Opin Hematol 11 (2004) 88-94
12. Jamieson C.H., Ailles L.E., Dylla S.J., Muijtjens M., Jones C., Zehnder J.L., et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 351 (2004) 657-667
13. Hehlmann R., Hochhaus A., Baccarani M., and European LeukemiaNet. Chronic myeloid leukaemia. Lancet 370 (2007) 342-350
14. Radich J.P., Dai H., Mao M., Oehler V., Schelter J., Druker B., et al. Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc Natl Acad Sci 103 (2006) 2794-2799
15. Ress A., and Moelling K. Bcr is a negative regulator of the Wnt signaling pathway. EMBO Rep 6 (2005) 1095-1100
16. Coluccia A.M., Vacca A., Dunarch M., Mologni L., Redaelli S., Bustos V.H., et al. Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation. EMBO J 26 (2007) 1456-1466
17. Zhao C., Blum J., Chen A., Kwon H., Jung S., Cook J., et al. Loss of β-Catenin Impairs the Renewal of normal and CML stem cells in vivo. Cancer Cell 12 (2007) 528-541
18. Sengupta A., Banerjee D., Chandra S., Banerji S.K., Ghosh R., Roy R., et al. Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression. Leukemia 21 (2007) 949-955
19. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 16 Spec No. 1 (2007) R50-R59
20. Smith L.T., Otterson G.A., and Plass C. Unraveling the epigenetic code of cancer for therapy. Trends Genet 23 (2007) 449-456
21. Liu T.H., Raval A., Chen S.S., Matkovic J.J., Byrd J.C., and Plass C. CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia. Cancer Res 66 (2006) 653-658
22. Rooney D.E., and Czepulkowski B.H. Human cytogenetics: A practical approach: malignancy and acquired abnormalities. 3rd ed. (2001), Oxford University Press Inc., New York
23. Li L.C., and Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 18 (2002) 1427-1431
24. Shmueli O., Horn-Saban S., Chalifa-Caspi V., Shimoish M., Ophir R., Benjamin-Rodrig H., et al. GeneNote: Whole genome expression profiles in normal human tissues. CR Biol 326 (2003) 1067-1072
25. Caldwell G.M., Jones C., Gensberg K., Jan S., Hardy R.G., Byrd P., et al. The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res 64 (2004) 883-888
26. Garcia-Hoyos M., Cantalapiedra D., Arroyo C., Esteve P., Rodríguez J., Riveiro R., et al. Evaluation of sFRP1 as a candidate for human retinal dystrophies. Mol Vis 10 (2004) 426-431
27. Baccarani M., Saglio G., Goldman J., Hochhaus A., Simonsson B., Appelbaum F., et al. Evolving concepts in the management of chronic myeloid leukaemia. Recommendations from an expert panel on behalf of the European Leukemianet. Blood 108 (2006) 1809-1820
28. Deininger M.W.N. Optimizing therapy of chronic myeloid leukemia. Exp Hematol 35 (2007) 144-154
29. Di Bacco A., Keeshan K., McKenna S.L., and Cotter T.G. Molecular abnormalities in chronic myeloid leukemia: deregulation of cell growth and apoptosis. Oncologist 5 (2000) 405-415
30. Jacquel A., Herrant M., Legros L., Belhacene N., Luciano F., Pages G., et al. Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage. FASEB J 17 (2003) 2160-2162
31. Suzuki H., Gabrielson E., Chen W., Anbazhagan R., van Engeland M., Weijenberg M.P., et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31 (2002) 141-149